MedPath

Vall d'Hebron Research Institute

Vall d'Hebron Research Institute logo
🇪🇸Spain
Ownership
Private
Established
1994-01-01
Employees
1K
Market Cap
-
Website
http://www.vhir.org

Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF

Conditions
Rheumatoid Arthritis
Interventions
Drug: Anti-TNF
First Posted Date
2016-06-17
Last Posted Date
2019-02-07
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
200
Registration Number
NCT02804204
Locations
🇪🇸

Hospital Virgen del Rocio, Sevilla, Andalucia, Spain

🇪🇸

Clínic de Barcelona, Barcelona, Catalunya, Spain

🇪🇸

Hospital de Basurto, Bilbao, Pais Vasco, Spain

and more 16 locations

Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

Not Applicable
Completed
Conditions
Coronary Artery Disease
Interventions
Device: Coroflex® ISAR Drug-eluting stent
Device: Ultimaster® Drug-eluting stent
First Posted Date
2016-05-27
Last Posted Date
2019-01-03
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
70
Registration Number
NCT02785237
Locations
🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Spain

🇪🇸

Hospital Clínic de Barcelona, Barcelona, Spain

🇪🇸

Hospital de León, León, Spain

Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function

Not Applicable
Completed
Conditions
Functional Gastrointestinal Disorders
Interventions
Dietary Supplement: Inulin
Dietary Supplement: Maltodextrine
First Posted Date
2016-04-04
Last Posted Date
2016-04-04
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
67
Registration Number
NCT02727166

Differences in Radial Artery Occlusion From Two Different Compressive Methods Used in Patients in Order to Achieve Homeostasis After Transradial Catheterization and Their Repercussion in Artery Functionality and Hand Mobility

Not Applicable
Completed
Conditions
Transradial Catheterization
Interventions
Other: Tensoplast
Other: Terumo
First Posted Date
2016-03-03
Last Posted Date
2016-03-03
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
274
Registration Number
NCT02697526
Locations
🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Spain

The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP).

Conditions
Hepatic Encephalopathy
Liver Cirrhosis
Portal Hypertension
First Posted Date
2016-02-26
Last Posted Date
2017-07-31
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
1000
Registration Number
NCT02692430
Locations
🇪🇸

Vall d'Hebron Hospital, Barcelona, Spain

Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve

Phase 3
Completed
Conditions
Bicuspid Aortic Valve
Interventions
Drug: Placebo
First Posted Date
2016-02-10
Last Posted Date
2021-02-18
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
220
Registration Number
NCT02679261
Locations
🇪🇸

Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain

🇪🇸

Hospital General Universitario Gregorio Marañón, Madrid, Spain

🇪🇸

Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain

and more 7 locations

STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer

Not Applicable
Completed
Conditions
Endometrial Neoplasms
Ovarian Neoplasms
Interventions
Procedure: Transperitoneal Laparoscopic aortic lymphadenectomy
Procedure: Extraperitoneal Laparoscopic aortic lymphadenectomy
First Posted Date
2016-02-08
Last Posted Date
2019-10-24
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
208
Registration Number
NCT02676726
Locations
🇪🇸

Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona, Barcelona, Spain

Health-related Quality of Life and Nursing-sensitive Outcomes in Mechanically Ventilated Patients

Completed
Conditions
Quality of Life
First Posted Date
2015-12-22
Last Posted Date
2015-12-22
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
184
Registration Number
NCT02636660

Effect of Prebiotics on Intestinal Gas Production, Microbiota and Digestive Symptoms

Not Applicable
Completed
Conditions
Healthy
Interventions
Dietary Supplement: Bimuno Galacto-oligo-saccharide
First Posted Date
2015-12-01
Last Posted Date
2015-12-01
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
20
Registration Number
NCT02618239

Hedonic Perception and Brain Activity Response to Meal

Not Applicable
Completed
Conditions
Dyspepsia
Interventions
Device: Functional brain MRI
Dietary Supplement: A warm ham and cheese sandwich and a 200 ml fruit juice
First Posted Date
2015-10-30
Last Posted Date
2017-07-27
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
80
Registration Number
NCT02592239
Locations
🇪🇸

Vall d'Hebron Research Institute, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath